4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-005747
Director sold 27,750 shares at an average $10.23 ($283,771)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCANGOS GEORGE A Director | 2024-02-16 | Sale 10b5-1 | −10,878 | $10.24 | $111,386 | 157,611 | D |
| SCANGOS GEORGE A Director | 2024-02-20 | Sale 10b5-1 | −16,872 | $10.22 | $172,385 | 140,739 | D |
| Open-market sales · 27,750 sh · avg $10.23 · $283,771 | |||||||
Loading xslF345X05/wk-form4_1708480944.xml…